SCOPUS 정보 검색 플랫폼

Volumn 114, Issue 5, 2014, Pages 665-673

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER trial)

(17) Valgimigli, Marco a Tricoci, Pierluigi b Huang, Zhen b Aylward, Philip E c Armstrong, Paul W d Van De Werf, Frans e Leonardi, Sergio f White, Harvey D g Widimsky, Petr h Harrington, Robert A i Cequier, Angel j Chen, Edmond k Lokhnygina, Yuliya b Wallentin, Lars l Strony, John m Mahaffey, Kenneth W i Moliterno, David J n

a ERASMUS MEDICAL CENTER (Netherlands)

b DUKE CLINICAL RESEARCH INSTITUTE (United States)

c FLINDERS UNIVERSITY (Australia)

d UNIVERSITY OF ALBERTA (Canada)

e UNIVERSITY OF LEUVEN (Belgium)

f FONDAZIONE IRCCS POLICLINICO SAN MATTEO (Italy)

g Uni Services House (New Zealand)

h CHARLES UNIVERSITY (Czech Republic)

i STANFORD UNIVERSITY SCHOOL OF MEDICINE (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PLACEBO; VORAPAXAR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BARE METAL STENT; BLEEDING; CEREBROVASCULAR ACCIDENT; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT DURATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; LACTONES; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PYRIDINES; RECEPTORS, THROMBIN; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84908372736 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2014.05.054 Document Type: Article

Times cited : (16)

References (6)

1
- 83655177669
- Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
- TRACER Investigators
- P. Tricoci, Z. Huang, C. Held, D.J. Moliterno, P.W. Armstrong, F. Van de Werf, H.D. White, P.E. Aylward, L. Wallentin, E. Chen, Y. Lokhnygina, J. Pei, S. Leonardi, T.L. Rorick, A.M. Kilian, L.H. Jennings, G. Ambrosio, C. Bode, A. Cequier, J.H. Cornel, R. Diaz, A. Erkan, K. Huber, M.P. Hudson, L. Jiang, J.W. Jukema, B.S. Lewis, A.M. Lincoff, G. Montalescot, J.C. Nicolau, H. Ogawa, M. Pfisterer, J.C. Prieto, W. Ruzyllo, P.R. Sinnaeve, R.F. Storey, M. Valgimigli, D.J. Whellan, P. Widimsky, J. Strony, R.A. Harrington, K.W. Mahaffey TRACER Investigators Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
- (2012) N Engl J Med , vol.366 , pp. 20-33
- Tricoci, P.¹ Huang, Z.² Held, C.³ Moliterno, D.J.⁴ Armstrong, P.W.⁵ Van De Werf, F.⁶ White, H.D.⁷ Aylward, P.E.⁸ Wallentin, L.⁹ Chen, E.¹⁰ Lokhnygina, Y.¹¹ Pei, J.¹² Leonardi, S.¹³ Rorick, T.L.¹⁴ Kilian, A.M.¹⁵ Jennings, L.H.¹⁶ Ambrosio, G.¹⁷ Bode, C.¹⁸ Cequier, A.¹⁹ Cornel, J.H.²⁰ more..

2
- 0035899289
- Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
- S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
- (2001) N Engl J Med , vol.345 , pp. 494-502
- Yusuf, S.¹ Zhao, F.² Mehta, S.R.³ Chrolavicius, S.⁴ Tognoni, G.⁵ Fox, K.K.⁶

3
- 28244459634
- Low-dose aspirin for the prevention of atherothrombosis
- C. Patrono, L.A. Garcia Rodriguez, R. Landolfi, and C. Baigent Low-dose aspirin for the prevention of atherothrombosis N Engl J Med 353 2005 2373 2383
- (2005) N Engl J Med , vol.353 , pp. 2373-2383
- Patrono, C.¹ Garcia Rodriguez, L.A.² Landolfi, R.³ Baigent, C.⁴

4
- 85058720552
- The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: Study design and rationale
- TRA*CER Executive and Steering Committees
- TRA*CER Executive and Steering Committees The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale Am Heart J 158 2009 327 334.e4
- (2009) Am Heart J , vol.158

5
- 13044263119
- A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase
- C. Trumel, B. Payrastre, M. Plantavid, B. Hechler, C. Viala, P. Presek, E.A. Martinson, J.P. Cazenave, H. Chap, and C. Gachet A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase Blood 94 1999 4156 4165
- (1999) Blood , vol.94 , pp. 4156-4165
- Trumel, C.¹ Payrastre, B.² Plantavid, M.³ Hechler, B.⁴ Viala, C.⁵ Presek, P.⁶ Martinson, E.A.⁷ Cazenave, J.P.⁸ Chap, H.⁹ Gachet, C.¹⁰

6
- 84859555815
- Vorapaxar in the secondary prevention of atherothrombotic events
- TRA 2P-TIMI 50 Steering Committee and Investigators
- D.A. Morrow, E. Braunwald, M.P. Bonaca, S.F. Ameriso, A.J. Dalby, M.P. Fish, K.A. Fox, L.J. Lipka, X. Liu, J.C. Nicolau, A.J. Ophuis, E. Paolasso, B.M. Scirica, J. Spinar, P. Theroux, S.D. Wiviott, J. Strony, S.A. Murphy TRA 2P-TIMI 50 Steering Committee and Investigators Vorapaxar in the secondary prevention of atherothrombotic events N Engl J Med 366 2012 1404 1413
- (2012) N Engl J Med , vol.366 , pp. 1404-1413
- Morrow, D.A.¹ Braunwald, E.² Bonaca, M.P.³ Ameriso, S.F.⁴ Dalby, A.J.⁵ Fish, M.P.⁶ Fox, K.A.⁷ Lipka, L.J.⁸ Liu, X.⁹ Nicolau, J.C.¹⁰ Ophuis, A.J.¹¹ Paolasso, E.¹² Scirica, B.M.¹³ Spinar, J.¹⁴ Theroux, P.¹⁵ Wiviott, S.D.¹⁶ Strony, J.¹⁷ Murphy, S.A.¹⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.